In the news: healthcare and medtech predictions
2022 was another rollercoaster year for the healthcare industry. Accelerated digital transformation, increased competition, a looming recession, and ongoing labor challenges left organizations with little choice but to take immediate action. At the same time, consumers are demanding seamless and highly personalized experiences while providers are scrambling to meet the pressures of these demands.
In this month’s news roundup, we’ll take a closer look at what’s ahead for 2023, starting with must-know predictions and trends. We’ll also reveal 5 key insights from the FDA’s recently announced list of AI-enabled medical devices. Plus, what’s going on with the medical supply chain? We’ll give you all the details on the current outlook.
Predictions 2023: Retail Health, Decentralized Trials, And Wellness Are On The Front Lines
The challenges for the industry are many, and in order to thrive in this dynamic market, healthcare organizations must invest in transformation and workforce talent or risk their market foothold. The future of healthcare depends on resilience and proactivity to propel value-based care and improve population health outcomes. Here’s what Forrester is predicting for 2023.
5 takeaways from the FDA’s list of AI-enabled medical devices
As medical devices that use artificial intelligence and machine learning appear in more hospitals and imaging labs across the country, new data from the FDA reveals how the agency has been fielding more submissions.
In fact, in 2022 alone, the FDA authorized 91 AI- or machine-learning-enabled medical devices. Learn more and see 5 key takeaways from the FDA’s list, including the specialty with the most AI tool innovations in recent years.
Plenty of phish: medical device manufacturers urged to assess cybersecurity risk and readiness
Propelled by the pandemic, medical devices are increasingly connected to technologies such as cloud-based capabilities, which increase the attack surface for hackers. Devices such as insulin pumps, heart pacemakers, inhalers, and wearables are particularly vulnerable as they track patient data in real-time and transmit information immediately to patient and doctor.
To mitigate risk, the FDA is encouraging manufacturers to leverage a “software bill of materials” (SBOM) program as a key building block in their software security and supply chain. The SBOM lists each software component making up a device, which can be shared to help track and manage vulnerabilities.
Looking Ahead: Risk Outlook for the Medical Supply Chain
Delayed and canceled elective surgeries, long lead times, significantly higher costs – this has been the unfortunate situation for many due to the pandemic. In particular, the medical device industry was deeply impacted by ongoing supply chain challenges and disruptions. Read on to see the current outlook for the industry and what’s predicted for the new year.
